Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126272093 | 12627209 | 3 | F | 201604 | 20160921 | 20160805 | 20160929 | EXP | JP-009507513-1607JPN013075 | MERCK | 34.00 | YR | F | Y | 55.00000 | KG | 20160929 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126272093 | 12627209 | 1 | PS | BELSOMRA | SUVOREXANT | 1 | Oral | 20 MG, QD | 3480 | MG | 204569 | 20 | MG | TABLET | QD | ||||
126272093 | 12627209 | 2 | SS | BELSOMRA | SUVOREXANT | 1 | Oral | DIVIDED DOSE FREQUENCY UNKNOWN | 3480 | MG | 204569 | 140 | MG | TABLET | 1X | ||||
126272093 | 12627209 | 3 | SS | BELSOMRA | SUVOREXANT | 1 | Oral | 20 MG, QD | 3480 | MG | 204569 | 20 | MG | TABLET | QD | ||||
126272093 | 12627209 | 4 | SS | LIMAS | LITHIUM CARBONATE | 1 | Oral | 700 MG, QD | D | 0 | 700 | MG | TABLET | QD | |||||
126272093 | 12627209 | 5 | SS | LIMAS | LITHIUM CARBONATE | 1 | Oral | DAILY DOSAGE UNKNOWN | D | 0 | TABLET | ||||||||
126272093 | 12627209 | 6 | SS | SENNARIDE | SENNOSIDES A AND B | 1 | Oral | 24 MG, QD | 0 | 24 | MG | TABLET | QD | ||||||
126272093 | 12627209 | 7 | SS | SENNARIDE | SENNOSIDES A AND B | 1 | Oral | UNK, ONCE | 0 | TABLET | 1X | ||||||||
126272093 | 12627209 | 8 | SS | SENNARIDE | SENNOSIDES A AND B | 1 | Oral | 24 MG, QD | 0 | 24 | MG | TABLET | QD | ||||||
126272093 | 12627209 | 9 | SS | LONASEN | BLONANSERIN | 1 | Oral | 4 MG, BID | 1184 | MG | D | 0 | 4 | MG | TABLET | BID | |||
126272093 | 12627209 | 10 | SS | LONASEN | BLONANSERIN | 1 | Oral | 8 MG, BID | 1184 | MG | D | 0 | 8 | MG | TABLET | BID | |||
126272093 | 12627209 | 11 | SS | LONASEN | BLONANSERIN | 1 | Oral | UNK, ONCE | 1184 | MG | D | 0 | TABLET | 1X | |||||
126272093 | 12627209 | 12 | SS | LONASEN | BLONANSERIN | 1 | Oral | 4 MG, QD | 1184 | MG | D | 0 | 4 | MG | TABLET | QD | |||
126272093 | 12627209 | 13 | SS | LONASEN | BLONANSERIN | 1 | Oral | 4 MG, BID | 1184 | MG | D | 0 | 4 | MG | TABLET | BID | |||
126272093 | 12627209 | 14 | SS | LONASEN | BLONANSERIN | 1 | Oral | 8 MG, BID | 1184 | MG | D | 0 | 8 | MG | TABLET | BID | |||
126272093 | 12627209 | 15 | C | THYRADIN-S | LEVOTHYROXINE | 1 | Oral | 50 MICROGRAM, QD | 0 | 50 | UG | TABLET | QD | ||||||
126272093 | 12627209 | 16 | C | LULLAN | PEROSPIRONE HYDROCHLORIDE | 1 | Oral | 16 MG, TID | 785.4 | MG | 0 | 16 | MG | TABLET | TID | ||||
126272093 | 12627209 | 17 | C | LULLAN | PEROSPIRONE HYDROCHLORIDE | 1 | Oral | 10.7 MG, TID | 785.4 | MG | 0 | 10.7 | MG | TABLET | TID | ||||
126272093 | 12627209 | 18 | C | LULLAN | PEROSPIRONE HYDROCHLORIDE | 1 | Oral | 16 MG, QD | 785.4 | MG | 0 | 16 | MG | TABLET | QD | ||||
126272093 | 12627209 | 19 | C | DEPAS | ETIZOLAM | 1 | Oral | 0.5 MG, AS NEEDED | 0 | .5 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126272093 | 12627209 | 1 | Insomnia |
126272093 | 12627209 | 4 | Schizophrenia |
126272093 | 12627209 | 6 | Constipation |
126272093 | 12627209 | 9 | Schizophrenia |
126272093 | 12627209 | 15 | Hypopituitarism |
126272093 | 12627209 | 16 | Schizophrenia |
126272093 | 12627209 | 19 | Headache |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126272093 | 12627209 | HO |
126272093 | 12627209 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126272093 | 12627209 | Dysphagia | |
126272093 | 12627209 | Headache | |
126272093 | 12627209 | Overdose | |
126272093 | 12627209 | Pneumonia aspiration | |
126272093 | 12627209 | Psychotic disorder | |
126272093 | 12627209 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126272093 | 12627209 | 1 | 20160118 | 20160702 | 0 | |
126272093 | 12627209 | 2 | 20160703 | 20160703 | 0 | |
126272093 | 12627209 | 3 | 20160706 | 0 | ||
126272093 | 12627209 | 4 | 20160702 | 0 | ||
126272093 | 12627209 | 5 | 20160703 | 20160703 | 0 | |
126272093 | 12627209 | 6 | 20160702 | 0 | ||
126272093 | 12627209 | 7 | 20160703 | 20160703 | 0 | |
126272093 | 12627209 | 9 | 20160413 | 20160426 | 0 | |
126272093 | 12627209 | 10 | 20160427 | 20160702 | 0 | |
126272093 | 12627209 | 11 | 20160703 | 20160703 | 0 | |
126272093 | 12627209 | 12 | 20160706 | 20160706 | 0 | |
126272093 | 12627209 | 13 | 20160707 | 20160711 | 0 | |
126272093 | 12627209 | 14 | 20160712 | 0 | ||
126272093 | 12627209 | 16 | 20160412 | 0 | ||
126272093 | 12627209 | 17 | 20160413 | 20160426 | 0 | |
126272093 | 12627209 | 18 | 20160427 | 20160517 | 0 | |
126272093 | 12627209 | 19 | 20160628 | 0 |